Yousif Capital Management, LLC Coherus Bio Sciences, Inc. Transaction History

Yousif Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	SELL	$3.79 - $8.3 $5,889 - $12,898	-1,554 Reduced 4.22%	35,304 $150,000
Q1 2023 May 02, 2023	SELL	$5.89 - $10.52 $23,501 - $41,974	-3,990 Reduced 9.77%	36,858 $252,000
Q4 2022 Jan 09, 2023	SELL	$5.69 - $10.07 $63,471 - $112,330	-11,155 Reduced 21.45%	40,848 $0
Q3 2022 Nov 04, 2022	SELL	$7.17 - $13.87 $7,772 - $15,035	-1,084 Reduced 2.04%	52,003 $500,000
Q2 2022 Aug 01, 2022	SELL	$5.86 - $13.23 $23,674 - $53,449	-4,040 Reduced 7.07%	53,087 $384,000
Q1 2022 May 12, 2022	SELL	$10.92 - $16.41 $18,782 - $28,225	-1,720 Reduced 2.92%	57,127 $738,000
Q4 2021 Jan 31, 2022	BUY	$15.81 - $18.99 $930,371 - $1.12 Million	58,847 New	58,847 $939,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Yousif Capital Management, LLC with notifications on news.